Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Relative safety of buffy coat platelet pools.

Devine D, Jenkins C, Howe D, Goldman M.

Transfusion. 2010 Jul;50(7):1591-2; author reply 1592-3. doi: 10.1111/j.1537-2995.2010.02631.x. No abstract available.

PMID:
20636534
2.

[Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].

Bux J, Müller K, Misterek J, Mueller-Eckhardt C.

Beitr Infusionsther. 1990;26:99-102. German.

PMID:
1703912
3.

The ethics of wasting the donor's gift of buffy coat.

Vamvakas EC.

Vox Sang. 2011 Feb;100(2):256-7; author reply 258-9. doi: 10.1111/j.1423-0410.2010.01405.x. Epub 2010 Sep 3. No abstract available.

PMID:
20825600
4.

Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit.

Rollins MD, Molofsky AB, Nambiar A, Pandey S, Weiskopf RB, Toy P.

Crit Care Med. 2012 Aug;40(8):2488-91. doi: 10.1097/CCM.0b013e3182544f85.

5.

Preparation, storage and quality control of platelet concentrates.

Tynngård N.

Transfus Apher Sci. 2009 Oct;41(2):97-104. doi: 10.1016/j.transci.2009.07.001. Epub 2009 Aug 20. Review.

PMID:
19699153
6.

Logistics of platelet concentrates.

[No authors listed]

Vox Sang. 2007 Feb;92(2):160-81. No abstract available.

PMID:
17298581
7.

Bacterial contamination in platelet concentrates.

Pietersz RN, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Ramírez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR.

Vox Sang. 2014 Apr;106(3):256-83. doi: 10.1111/vox.12098. Review. No abstract available.

PMID:
24654780
8.
9.

Platelet transfusion associated with acute lung injury after coronary artery bypass grafting.

Fitzmaurice GJ, Parissis HD.

Ann Thorac Surg. 2011 Jun;91(6):1977-9. doi: 10.1016/j.athoracsur.2010.11.076.

PMID:
21619998
10.

Treating thrombocytopenia with pathogen-reduced platelets.

Sandler SG.

Curr Hematol Rep. 2006 Mar;5(1):53-4. No abstract available.

PMID:
16537046
11.

A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.

Kleinman S, Grossman B, Kopko P.

Transfusion. 2010 Jun;50(6):1312-21. doi: 10.1111/j.1537-2995.2010.02659.x. Epub 2010 Apr 27.

PMID:
20456690
12.

A critical comparison of platelet preparation methods.

Vassallo RR, Murphy S.

Curr Opin Hematol. 2006 Sep;13(5):323-30. Review.

PMID:
16888436
13.

Do manual and automated processes with distinct additive solutions affect whole blood-derived platelet components differently?

Nguyen KA, Chavarin P, Arthaud CA, Cognasse F, Garraud O.

Blood Transfus. 2013 Jan;11(1):152-3. doi: 10.2450/2012.0010-12. Epub 2012 Jul 12. No abstract available.

14.

Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.

Riggert J, Humpe A, Simson G, Köhler M.

Vox Sang. 1998;74(3):182-8.

PMID:
9595646
15.

The impact of discontinuation of 7-day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments.

Kleinman S, Dumont LJ, Tomasulo P, Bianco C, Katz L, Benjamin RJ, Gajic O, Brecher ME.

Transfusion. 2009 May;49(5):903-12. doi: 10.1111/j.1537-2995.2008.02048.x. Epub 2009 Jan 5.

PMID:
19170988
16.

[Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].

Müller N, Krüssel H.

Beitr Infusionsther Transfusionsmed. 1994;32:52-4. German.

PMID:
9480156
17.

Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.

Vasconcelos E, Figueiredo AC, Seghatchian J.

Transfus Apher Sci. 2003 Aug;29(1):13-6.

PMID:
12877887
18.

Clinical aspects of treatment with platelet concentrates.

Lanzer G.

Acta Anaesthesiol Scand Suppl. 1996;109:141-3. No abstract available.

PMID:
8901986
19.

In reply to: "Is the SCID mouse model applicable to human acute lung injury?".

Goodrich RP.

Transfusion. 2012 Nov;52(11):2489-92; author reply 2492-4. doi: 10.1111/j.1537-2995.2012.03852.x. No abstract available.

PMID:
23140431

Supplemental Content

Support Center